
Translating…
June 23 (Reuters) – GW Pharmaceuticals PLC:
* GW PHARMACEUTICALS ANNOUNCES THAT EPIDYOLEX® (CANNABIDIOL) HAS BEEN RECLASSIFIED BY THE UK HOME OFFICE AS A SCHEDULE 5 DRUG
* CHANGE WILL TAKE EFFECT IMMEDIATELY IN ALL FOUR OF CONSTITUENT NATIONS OF UK – WITH NORTHERN IRELAND Source text for Eikon: Further company coverage:
Our Standards:The Thomson Reuters Trust Principles.